• Medical_Professionals
• Medical_students
• Nurses

Dear Colleagues,

On behalf of the University of Cincinnati and CURRENT PSYCHIATRY, it is my pleasure to invite you to attend our 13th Annual Psychopharmacology Update.

At this full-day course, nationally renowned faculty will cover pharmacotherapies for treatment-resistant patients, including strategies for treating mood disorders, OCD, insomnia, alcoholism and substance use, as well as schizophrenia and related psychoses.

This well-established one-day CME symposium offers an outstanding opportunity for education and networking with minimal disruption to your busy schedule. You will get in-depth analysis from our expert faculty and ample time to query them on topics that will help keep your practice ahead of the curve.

I look forward to hosting this symposium in Cincinnati at the Marriott Kingsgate Conference Center (across the street from UC Medical Center). I hope to see attendees from last year as well as those who are attending for the first time.

Sincerely,
Henry A. Nasrallah, MD
Symposium Director
The Sydney W. Souers Professor
Chair, Department of Neurology and Psychiatry
St. Louis University School of Medicine
St. Louis, Missouri

Henry A. Nasrallah, MD
The Sydney W. Souers Professor and Chair
Department of Neurology and Psychiatry
St. Louis University School of Medicine
St. Louis, Missouri

Dr. Henry Nasrallah is an internationally recognized psychiatrist, educator, and researcher. He received his BS and MD degrees at the American University of Beirut (AUB). Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the NIH, he served as a faculty member at the University of California, San Diego and the University of Iowa before assuming the chair of the Ohio State University Department of Psychiatry for twelve years. In 2003, following a research sabbatical, he joined the University of Cincinnati College of Medicine as Associate Dean and Professor of Psychiatry and Neuroscience .Dr. Nasrallah is currently The Sydney W. Souers Professor and Chair of the Department of Neurology and Psychiatry at the St. Louis University School of Medicine in St. Louis, Missouri.

Dr. Nasrallah was the director of the Schizophrenia Program at the University of Cincinnati, College of Medicine. His research focuses on the neurobiology and psychopharmacology of schizophrenia and related disorders. He has published more than 360 scientific articles and 400 abstracts, as well as 11 books. He is Editor-In-Chief of two prominent journals (Current Psychiatry and Schizophrenia Research) and is the co-founder of the Schizophrenia International Research Society (SIRS). He has been board-certified in both adult and geriatric psychiatry. He is a Fellow of the American College of Neuropsychopharmacology (ACNP), fellow of the American College of Psychiatrists, distinguished life fellow of the American Psychiatric Association and past President of the Cincinnati Psychiatric Society and the American Academy of Clinical Psychiatrists, and is currently the president of the Ohio Psychiatric Physicians Education and Research Foundation, and President of the University of Cincinnati College of Medicine Faculty Forum (which represents 1500 faculty members). He has twice received the NAMI Exemplary Psychiatrist Award and was recognized as the U.S. Teacher of the Year by Psychiatric Times. He has received more than 80 federal, industry, and foundation research grants and is listed in several editions of Best Doctors in America.

2014 Faculty

Karl Doghramji, MD
Professor of Psychiatry, Neurology, and Medicine
Medical Director, Jefferson Sleep Disorders Center
Program Director, Fellowship in Sleep Medicine
Thomas Jefferson University
Philadelphia, PA 

Dr. Doghramji is a professor and director of the Sleep Disorders Center at Thomas Jefferson University Hospital in Philadelphia. He has held numerous committee positions with the American Academy of Sleep Medicine and has served as an examiner for the American Board of Psychiatry and Neurology and the American Board of Sleep Medicine. He has authored more than 150 journal publications and book chapters and has edited and written 3 books. He has been the recipient of numerous grants. His published works and research focus on a wide variety of sleep disorders, including excessive daytime somnolence, sleep apnea syndrome, and insomnia, as well as depression and anxiety disorders.

Mark S. Gold, MD
University of Florida Alumni Distinguished Professor (2011-2015) 
University of Florida Distinguished Professor 
Donald R. Dizney Eminent Scholar
Departments of Psychiatry, Neuroscience, Anesthesiology, Community Health & Family Medicine
Chairman, Department of Psychiatry
University of Florida College of Medicine and McKnight Brain Institute
Gainesville, FL

Dr. Gold is the Donald Dizney Eminent Scholar, Distinguished Professor and Chair of Psychiatry. Recently, he has also been selected as the 17th University of Florida’s Distinguished Alumni Professor. He is currently serving his second two year, University-wide term in this leadership position. Prior to assuming the position as Chair he was a Distinguished Service Professor in the Departments of Psychiatry, Neuroscience, Anesthesiology, and Community Health and Family Medicine at the University of Florida College of Medicine located in Gainesville, Florida. He is also a member of the McKnight Brain Institute and a Founder of the U.F. Center for Alcohol and Drug Research and Education (CARE). Dr. Gold is a teacher of the year, researcher and inventor who has worked for nearly 40 years to develop models for understanding the effects of tobacco, cocaine, and other drugs and also food on the brain and behavior. Dr. Gold has developed translational research models which have led to new treatments for addicts and also conceptualized hypotheses which were more than novel but also yielded new approaches to treat patients. He has been recognized many times for his innovations and also as an inventor.

Joseph F. Goldberg, MD 
Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York
Director, Affective Disorders Research Program
Silver Hill Hospital,
New Canaan, CT

Dr. Goldberg is a psychiatrist with 25 years of experience in academic research studying the features and treatment of mood disorders, particularly bipolar disorder and other forms of depression. He supervises and teaches psychopharmacology to medical students and residents at the Mount Sinai School of Medicine, and maintains a private practice in Norwalk, CT. He has published over 160 original research publications in major psychiatric journals on topics related to mood disorders, focusing on the use of anticonvulsant mood stabilizers and atypical antipsychotics, safety risks with antidepressants in bipolar disorder, management of drug side effects, features related to rapid cycling bipolar disorder, suicide risk in bipolar disorder, cognitive dysfunction in bipolar disorder, pharmacogenetics in bipolar disorder, comorbid psychiatric disorders in bipolar disorder, and the long-term functional course and outcome of bipolar disorder and depression.

Wayne K. Goodman, MD
Professor and Chair, Psychiatry
Professor, Neuroscience
Icahn School of Medicine
Chief of the Division of Tics, OCD, and Related Disorders (DTOR)
Chairman, Department of Psychiatry
Mount Sinai School of Medicine
New York, NY

On July 1, 2009, Dr. Goodman was appointed Professor and Chairman of the Department of Psychiatry at the Mount Sinai School of Medicine in New York City. He is the Esther and Joseph Klingenstein Professor of Psychiatry and Professor in the Department of Neuroscience

Prior to joining Mt. Sinai, he served as Director, Division of Adult Translational Research and Treatment Development (DATR), at the National Institute of Mental Health in Bethesda, Maryland from 2007-2009. He has conducted pioneering research in the field of Obsessive-Compulsive Disorder (OCD) and is the principal developer of the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), the gold standard for assessing OCD. He is co-founder of the Obsessive Compulsive Foundation, the national patient advocacy organization for this disorder.

As Chair of Psychiatry, Dr. Goodman works closely with the new Mount Sinai Brain Institute to conduct research on neuropsychiatric disorders such as schizophrenia, Alzheimer’s disease, and mood disorders. 

Dr. Goodman is an expert psycho-pharmacologist who previously served as Chair of the Food and Drug Administration’s (FDA's) Psychopharmacologic Drug Advisory Committee.

His primary areas of research interest are obsessive compulsive disorder (OCD) and related disorders such as Tourette’s Syndrome (TS) in children and adults. He is interested in advancing the treatment of OCD through a better understanding of its pathophysiology. During a span of 20 years, he has investigated the phenomenology, neurobiology and treatment of OCD. In recent years, he has focused on developing approaches to treatment-resistant OCD including the study of Deep Brain Stimulation (DBS).

John M. Oldham, MD, MS
Past President
American Psychiatric Association
Chief of Staff
The Menninger Clinic
Houston, Texas

Dr. Oldham leads the medical staff and oversees research at the Menninger Clinic, while at Baylor College of Medicine, he oversees clinical care, including the public psychiatry division of Harris County Hospital District and The Baylor Psychiatry Clinic. He is also the host of Mindscape, a podcast series about mental health issues.

An expert in personality disorders and recognized internationally as a leader in psychiatric medicine, Dr. Oldham is board certified in psychiatry, psychoanalysis and forensic psychiatry.

Throughout his career, Dr. Oldham has been active in the American Psychiatric Association, which serves more than 38,000 psychiatrists worldwide. He is a past president of the organization. Dr. Oldham has also served a two-year term as president of the American College of Psychiatrists.

Before joining Menninger in 2007, he served as professor and chairman of Psychiatry & Behavioral Sciences and executive director of the Institute of Psychiatry at the Medical University of South Carolina.

At Columbia University, Dr. Oldham was the Elizabeth K. Dollard Professor and acting chairman of the Department of Psychiatry. He also directed the New York State Psychiatric Institute and was chief medical officer of the New York State Office of Mental Health.

Dr. Oldham received his medical degree from Baylor College of Medicine and completed psychiatric residency training at Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute. He completed psychoanalytic training at the Columbia Psychoanalytic Center.

Murray B. Stein MD, MPH
Professor of Psychiatry and Family and Preventive Medicine
Director, Anxiety & Traumatic Stress Disorders Program
University of California San Diego
La Jolla, CA

Dr. Stein is Professor of Psychiatry and Family & Preventive Medicine at the University of California San Diego (UCSD), where he directs the Anxiety & Traumatic Stress Disorders Program. Dr. Stein graduated from the University of Manitoba and completed his residency and post-residency fellowship at the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland, USA. He subsequently completed a Master of Public Health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland.

Dr. Stein’s research interests include the epidemiology, neurobiology, and treatment of anxiety disorders especially social phobia, panic disorder, and posttraumatic stress disorder. He has written or co-written over 400 peer-reviewed scientific articles on these topics, including in journals such as The Lancet, Journal of the American Medical Association, American Journal of Psychiatry, and Archives of General Psychiatry. He is co-editor, with Martin Antony PhD, of the Oxford Handbook of Anxiety and Related Disorders (2009). His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment-resistant anxiety disorders, and functional neuroimaging research in anxiety and trauma-related disorders. He is Principal Investigator and Director of the Department of Defense-funded (2008-2013) INjury and TRaumatic STress (INTRuST) Consortium, which studies treatments for Posttraumatic Stress Disorder and Traumatic Brain Injury. He is also Co-Principal Investigator (with Robert Ursano MD) of Army STARRS, an NIMH-funded project (2009-2014) investigating risk factors for suicide and other deployment-related disorders.

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Submission Info

Benefits of Participating in the Psychopharmacology Update:

• Opportunity for exposure at a top-flight conference featuring nationally renowned faculty.
• Face-to-face access to more than 250 patient-seeing psychiatrists and other mental health professionals in an intimate venue.
• Network with and engage psychiatrists in an educational setting conducive to mutual learning.
• Opportunity to create programs that deliver cost-effective print and online enduring materials through Current Psychiatry, Annals of Clinical Psychiatry.

Registration Coordinator
Global Academy for Medical Education
455 S. Fourth Street
Suite 650
Louisville, KY 40202
kkirchner@hqtrs.com
PH: (502) 574-9023 
FX: (502) 589-3602

Sales and Sponsorships

Sales Manager, Integrated Programs
Global Academy for Medical Education
7 Century Dr., Ste 302
Parsippany, NJ 07054
gpawlak@frontlinemedcom.com
PH: (973) 206-2328

Speakers and Faculty

Conference Manager
Global Academy for Medical Education
7 Century Dr., Ste 302
Parsippany, NJ 07054
mtroiano@frontlinemedcom.com 
PH: (973) 206-2354

Marketing

Conference Marketing Director
Global Academy for Medical Education
7 Century Dr., Ste 302
Parsippany, NJ 07054
kwenzler@frontlinemedcom.com
PH: (973) 206-8092

Conference Director

Vice President, Events
Global Academy for Medical Education
7 Century Dr., Ste 302
Parsippany, NJ 07054
dsmall@frontlinemedcom.com
PH: (973) 206-9067